Cabaletta Bio Inc (CABA)
Cabaletta Bio Reports Second Quarter 2026 Financial Results and Provides Business Update
REBORN COFFEE, INC. (REBN)
Reborn Coffee Signs $20 Million Annual Supply Agreement with The Mighty Oak, Strengthening Its Revenue Base and Profitability Through the Conversion of Existing Supply Volume
INDONESIA ENERGY CORP LTD (INDO)
Indonesia Energy Corporation Reports Progress on Drilling of K-29 Well
GDS HOLDINGS LTD (GDS)
GDS Holdings Limited Reports Second Quarter 2026 Results
SPRINKLR, INC. (CXM)
Sprinklr Appoints Jordi Ribas to Board of Directors
MINK THERAPEUTICS, INC. (INKT)
MiNK Therapeutics Reports Second Quarter 2026 Financial Results and Reports Observations from Randomized Phase 2 Trial of agenT-797 in Acute Lung Injury
CREATIVE REALITIES, INC. (CREX)
Creative Realities Reports Fiscal 2026 Second Quarter Results
KARYOPHARM THERAPEUTICS INC. (KPTI)
Karyopharm Reports Second Quarter 2026 Financial Results and Highlights Continued Progress Toward Myelofibrosis sNDA Submission
CORMEDIX INC. (CRMD)
Cormedix Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
NERVGEN PHARMA CORP. (NGEN)
NervGen Reports Second Quarter 2026 Financial Results and Provides Business Updates
ADC THERAPEUTICS SA (ADCT)
ADC Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Updates
CABALETTA BIO, INC. (CABA)
Cabaletta Bio Reports Second Quarter 2026 Financial Results and Provides Business Update
ABEONA THERAPEUTICS INC. (ABEO)
Abeona Therapeutics® Reports Second Quarter 2026 Results and Provides Business Update
ASCENDIS PHARMA A/S (ASND)
Ascendis Pharma Reports Second Quarter 2026 Financial Results
NORTHERN POTASH CO. (NPTH)
NEUPATH HEALTH REPORTS SECOND QUARTER 2026 RESULTS